NeoDynamics CEO Anna Eriksrud will present the company at Redeye Growth Day on 2 June 2021, at 15.20 CET. The presentation will be casted live and can be followed at the following link: https://www.redeye.se/events/808637/redeye-growth-day-2021.
The presentation which will be held in English. It will be made available afterwards on the same link as above, on NeoDynamics company page at Redeye, and on NeoDynamics website www.neodynamics.com.
For further information, please contact:
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company has developed an innovative biopsy system, NeoNavia. The pulse biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. The system is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. NeoNavia is evaluated at leading clinics in UK, Germany and Sweden. The share is traded on Spotlight Stock Market.